Neurocarrus' Convertible Note Round

Neurocarrus raised a round of funding on October 27, 2017.

Neurocarrus is a biotechnology company developing a novel drug delivery technology to safely disrupt pain signals without addiction-forming medications or disruption of muscular control.…

Articles about Neurocarrus' Convertible Note Round: